<DOC>
	<DOCNO>NCT02439866</DOCNO>
	<brief_summary>Patients diagnosed NAION within 14 day onset include . Patients randomize 3 group . Group 1 control consist 30 patient receive gelatinous capsule fill sugar placebo . Group 2 steroid consist 30 patient receive methylprednisolone ( Solu-Medrol , Pharmacia Pharmaceutical Company , Belgium ) 500 mg twice day 3 day follow 2 week oral prednisolone 1mg/kg/day . Thirty patient group 3 oxygen receive 100 % normobaric oxygen face mask sit position , flow rate 5 liter per minute 1 hour twice day two week Functional structural outcome assess 1 6 month follow treatment . Best correct visual acuity main outcome measure , mean deviation index visual field test peripapillary retinal nerve fiber layer thickness secondary outcome measure .</brief_summary>
	<brief_title>Outcomes Steroid Oxygen Therapy Versus Placebo Therapy Non-arteritic Anterior Ischemic Optic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Patients recent onset ( within 2 week ) nonarteritic ischemic optic neuropathy presence glaucoma , ocular , neurologic , systemic disease may influence visual acuity visual field ; abnormal result laboratory assessment , include abnormally elevate erythrocyte sedimentation rate positive serum Creactive protein ; history previous ocular surgery ; history prior treatment type NAION ; systemic condition diabetes mellitus poorly control hypertension</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>